Opportunity type
Internship
Routes to impact
Skill-building & building career capital
Learning about important cause areas
Testing your fit for a certain career path
Direct high impact on an important cause
Deadline
2026-01-10
Location
Burlingame, CA
Description
Genesis Therapeutics seeks early career computational chemistry scientists to develop advanced methodologies combining machine learning and physics-based methods for small molecule property predictions.
- Scientists develop computational chemistry/physics methodologies, collaborate on hybrid physics/ML methods, and work with medicinal chemists to improve drug discovery platform
- Requires graduate student background with proven track record in computational chemistry/physics methods and skilled Python programming abilities
- Offers competitive salary/equity, full benefits, one-on-one mentorship, and opportunity to work on high-impact research immediately deployed for medicine discovery
- Application deadline January 9, 2026 with interviews starting January 26 and target start date May-June 2026
- Company raised $200M Series B with $300M+ total funding, headquartered in Burlingame, CA with integrated San Diego laboratory focused on challenging/undruggable targets
This text was generated by AI. If you notice any inconsistencies, please let us know using this form
Join 60k subscribers and sign up for the EA Newsletter, a monthly email with the latest ideas and opportunities